Claritas Pharmaceuticals
About:
Claritas Pharmaceuticals is pioneering the development of a next generation of cannabinoid therapeutics.
Website: https://claritaspharma.com
Twitter/X: claritaspharma
Top Investors: Obsidian Global Partners, Alumina Partners
Description:
Kalytera is pioneering the development of a next generation of cannabinoid therapeutics. Kalytera is focused first on developing a new class of proprietary cannabidiol (“CBD”) therapeutics.
Total Funding Amount:
$31.3M
Headquarters Location:
San Rafael, California, United States
Founded Date:
2004-10-15
Contact Email:
info(AT)claritaspharma.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2022-01-12
IPO Status:
Public
Industries:
© 2025 bioDAO.ai